ARCHIVES

NCI Contract Awards

This article is from The Cancer Letter archive.

Vol. 22 No. 42 | November 1, 1996

Download PDF Visit The Full Archive

Related Articles

NCI Research Plan Proposes Spending $5 Billion In FY2002.

November 3, 2000

mTOR Inhibitor Improves PFS In Metastatic Sarcoma Patients

February 25, 2011

HOP Development Proceeding Guidelines For New, Revision Of Existing Control Grants Being Written

July 24, 1981

In Brief: Lichter, Bailes Lead ASCO; NCI Names Vande Woude Basic Sciences Director

May 22, 1998

FDA Issues MedWatch Warning, Begins Safety Review Of Prostate Cancer Drugs

May 7, 2010

New Chemoprevention Program Will Get “Whatever Money It Need;” Clinical Trials In New Division

July 25, 1980